Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project. - Taylor MR; Anderson JR; Park JR; Irwin MS; Applebaum MA; Pinto NR; Streby K; Federico SM; Rosswog C; Ohira M; Kao PC; London WB; et al. (Pediatric blood & cancer, 2025)